ATE364395T1 - Konjugat-impfstoffe zur vorbeugung der zahnkaries - Google Patents

Konjugat-impfstoffe zur vorbeugung der zahnkaries

Info

Publication number
ATE364395T1
ATE364395T1 AT99916570T AT99916570T ATE364395T1 AT E364395 T1 ATE364395 T1 AT E364395T1 AT 99916570 T AT99916570 T AT 99916570T AT 99916570 T AT99916570 T AT 99916570T AT E364395 T1 ATE364395 T1 AT E364395T1
Authority
AT
Austria
Prior art keywords
glucan
cell
dental caries
dependent
mutans
Prior art date
Application number
AT99916570T
Other languages
English (en)
Inventor
Andrew Lees
Martin A Taubman
Daniel J Smith
Original Assignee
Andrew Lees
Martin A Taubman
Daniel J Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew Lees, Martin A Taubman, Daniel J Smith filed Critical Andrew Lees
Application granted granted Critical
Publication of ATE364395T1 publication Critical patent/ATE364395T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99916570T 1998-04-10 1999-04-09 Konjugat-impfstoffe zur vorbeugung der zahnkaries ATE364395T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8131598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
ATE364395T1 true ATE364395T1 (de) 2007-07-15

Family

ID=22163404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916570T ATE364395T1 (de) 1998-04-10 1999-04-09 Konjugat-impfstoffe zur vorbeugung der zahnkaries

Country Status (8)

Country Link
US (2) US7101562B1 (de)
EP (1) EP1069909B1 (de)
JP (1) JP2002511422A (de)
AT (1) ATE364395T1 (de)
AU (1) AU761927B2 (de)
CA (1) CA2325338C (de)
DE (1) DE69936296D1 (de)
WO (1) WO1999052548A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
WO1999052548A2 (en) * 1998-04-10 1999-10-21 Andrew Lees Conjugate vaccines for the prevention of dental caries
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2002058711A1 (en) 2001-01-16 2002-08-01 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
JP2005531511A (ja) * 2002-03-07 2005-10-20 ザ フォーシス インスティチュート グルカン結合タンパク質の免疫原性
WO2005072778A2 (en) * 2004-01-29 2005-08-11 Biosynexus, Inc. Use of amino-oxy functional groups in the preparation of vaccines conjugates
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
CA2762366C (en) * 2009-07-31 2017-09-19 National Research Council Of Canada H. pylori lipopolysaccharide outer core epitope
CA2836140C (en) 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
AU2010351576B2 (en) 2010-04-23 2014-08-14 FinaBioSolutions, LLC Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
US20140261231A1 (en) * 2013-03-13 2014-09-18 Ronald K. Dunton Pet products having oral care properties
US9833390B2 (en) * 2015-08-12 2017-12-05 Provseal Llc Dental device for inhibition of plaque, calculus and gingivitis
RU2685492C1 (ru) * 2017-12-27 2019-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Дальневосточный государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ДВГМУ Минздрава России) Способ профилактики кариеса зубов у детей раннего возраста воздействием на управляемые факторы риска его развития

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150116A (en) 1978-02-21 1979-04-17 Forsyth Dental Infirmary For Children Immunization against dental caries with glucosyltransferase antigens
US4250262A (en) 1979-12-14 1981-02-10 Forsyth Dental Infirmary For Children Method of preparing a purified glucosyltransferase
DE3224788A1 (de) 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
US4438200A (en) 1982-09-13 1984-03-20 Forsyth Dental Infirmary For Children Method for the preparation of glucosylranferase
US5126131A (en) 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US5370871A (en) 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
FR2581877B1 (fr) 1985-05-14 1987-12-18 Louvain Universite Catholique Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
IL96475A0 (en) 1989-11-29 1991-08-16 Innovative Tech Center Chimeric proteins
ATE245446T1 (de) 1992-02-11 2003-08-15 Jackson H M Found Military Med Dualer träger für immunogene konstrukte
DE69332539T2 (de) 1992-05-01 2003-04-10 Forsyth Dental Infirmary Synthetische Peptide als Impfstoffe für Zahnkaries
ATE254475T1 (de) 1993-09-22 2003-12-15 Jackson H M Found Military Med Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
EP0749488A1 (de) 1994-03-03 1996-12-27 Genentech, Inc. Anti il - 8 monoklonale antikörper für die behandlung von entzündlichen erkrankungen
WO1999052548A2 (en) * 1998-04-10 1999-10-21 Andrew Lees Conjugate vaccines for the prevention of dental caries

Also Published As

Publication number Publication date
AU761927B2 (en) 2003-06-12
WO1999052548A9 (en) 2001-06-07
AU3486499A (en) 1999-11-01
DE69936296D1 (de) 2007-07-26
EP1069909A2 (de) 2001-01-24
WO1999052548A3 (en) 1999-12-02
JP2002511422A (ja) 2002-04-16
CA2325338C (en) 2015-06-23
US7101562B1 (en) 2006-09-05
EP1069909B1 (de) 2007-06-13
WO1999052548A2 (en) 1999-10-21
US20070065465A1 (en) 2007-03-22
CA2325338A1 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
ATE364395T1 (de) Konjugat-impfstoffe zur vorbeugung der zahnkaries
DK0778781T3 (da) Pneumokok-polysaccharid-rekombinant pneumolysin-konjugat-vacciner til immunisering mod pneumokokinfektioner
EP0009872B1 (de) Antigen-Zusammensetzung, Verfahren zu deren Herstellung und pharmakologische oder dentale Zusammensetzungen, die diese Antigen-Zusammensetzung oder deren Antikörper enthalten
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
ZA200207992B (en) Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid for induction of an immune response to amyloid and amyloid deposits.
DE68917126D1 (de) T-zellen-epitope als träger für einen konjugierten impfstoff.
TR200102736T2 (tr) Aşı.
DK1089760T3 (da) Kunstige T-hjælpecelleepitoper som immunstimulatorer for syntetiske peptidimmunogener
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
ATE486887T1 (de) Trägerprotein eines polyepitops
TR199801722T2 (xx) Peptit imm�nojenler.
HK1043943A1 (zh) 肺炎鏈球菌蛋白質和疫苗
EP0866133A3 (de) Einer Gruppe B Streptococcus Impfstoff
NZ309713A (en) Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
WO2003065973A3 (en) Multivalent streptococcal vaccine compositions and methods for use
MY125000A (en) Novel compositions
EP1267922A1 (de) Polysaccharidkonjugate von pneumokokken als impfstoff gegen tetanus und diphterie
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
EP1266662A3 (de) Synthetische Peptide Impfstoffe für Zahnkaries
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
WO2004078099A3 (en) Compositions and methods for the generation of protective immune response against malaria
WO2003075845A3 (en) Immunogenicity of glucan binding protein
DE60333027D1 (de) Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties